Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

Only a couple weeks removed from seeing a bunch of weird robots at CES, scientists have unveiled a new innovation in the world of creepy robotics — the detachable crawling robotic hand. Of course, one ...

I have read more than my fair share of LitRPG books, but Dungeon Crawler Carl has been a contender for my overall favorite series since I first picked up book one. In short, it's an ongoing story ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

A powerful web crawler built with Python and Playwright that can recursively scrape websites, extract links, subdomains, and JavaScript files, and save all discovered pages to local files.

Ken Johnson has tried noisy tactics to encourage the 550-pound houseguest in his crawl space to leave. He is not sure it’s working. By Christine Hauser In June, Ken J. Johnson discovered the underside ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...